Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Lariat Biosciences is an employee-owned biotechnology start-up.
bioSyntagma develops molecular fingerprint for diagnosing and discovering disease.
Prokaryotics is a biopharmaceutical company focused on the discovery and development of novel antibiotic classes.
SolveBio deploys technology and on-demand expertise to drive precision medicine. We monitor, gather, and secure Genomic Intelligence.
Blackfynn is a technology-driven, life-sciences company dedicated to transforming the way neurological diseases are diagnosed and treated.
Insightfil enables pharmacies to offer personalized care to their patients, increasing pharmacy profits while improving patient health.
A live image of radiation therapy
A non-profit missioned to increase openness, integrity, and reproducibility in the sciences.
IntelliWheels designs, manufactures, and commercializes wheelchair accessories.
The Global Registry of Biorepositories is a clearing house of information on biological collections in biorepositories.
Commence Bio is a therapeutics company developing methods to improve the anti-inflammatory properties of stem cells.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Life Science, Software, Medical Device. The firm invests across 20 different industry categories.
Among tracked funding rounds, Global Registry of Biorepositories received $45.0M in a Series Unknown round. National Institutes of Health's total known invested capital is $2.5B.
National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.